Transforming tumors into ‘high-risk bombs’ triggers a neoantigen storm and amplifies immune responses
Authors:
- 24 February 2025
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 380, 1080-1094
Abstract
No abstract availableKeywords
Funding Information
- Excellent Young Talents Fund Program of Higher Education Institutions of Anhui Province (2023AH030065)
- Anhui Provincial Quality Engineering Project (2022xscx100)
- Anhui Provincial Department of Education (2022AH040077)
- Anhui Provincial Department of Education (gxbjZD2021056)
- National Natural Science Foundation of China (52203154)
- National Natural Science Foundation of China (2021ZC06)
- Chengdu University of Traditional Chinese Medicine
- Anhui University of Chinese Medicine
This publication has 33 references indexed in Scilit:
- Engineered Bacterial Biomimetic Vesicles Reprogram Tumor-Associated Macrophages and Remodel Tumor Microenvironment to Promote Innate and Adaptive Antitumor Immune ResponsesACS Nano, 2024
- Targeting Lysosome for Enhanced Cancer Photodynamic/Photothermal Therapy in a “One Stone Two Birds” PatternACS Applied Materials & Interfaces, 2023
- Autophagy‐dependent regulation of MHC‐I molecule presentationJournal of Cellular Biochemistry, 2023
- Neoantigen-directed therapeutics in the clinic: where are we?Trends in Cancer, 2023
- Pharmacologic modulation of RNA splicing enhances anti-tumor immunityCell, 2021
- Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanismsPharmacological Research, 2021
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen PredictionCell, 2020
- RNA Splicing and CancerTrends in Cancer, 2020
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancerNature, 2017
- Targeting neoantigens to augment antitumour immunityNature Reviews Cancer, 2017